Tag: ANDA pathway
Dec, 3 2025
Complex Generic Drugs: Why Some Products Are Harder to Approve
Complex generic drugs face unique scientific and regulatory hurdles that make approval far harder than for simple generics. Despite high patient need, few reach the market due to cost, complexity, and unclear FDA expectations.